NCT05657249View on ClinicalTrials.gov

Alternative Surveillance Program for Patients With High Risk Group of HCC

NAActive, not recruitingINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

Non-contrast focused MRI

non-contrast liver MRI focusing on HCC surveillance in a short scan time.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Severance Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Korea University Guro Hospital

OTHER

lead

Seoul National University Hospital

OTHER

NCT05657249 - Alternative Surveillance Program for Patients With High Risk Group of HCC | Biotech Hunter | Biotech Hunter